|
Abbott Named One of the Top 10 Companies for Scientists
|
01 June 2009 |
|
Abbott's XIENCE V(R) Demonstrates Impressive Results in SPIRIT V Study
|
22 May 2009 |
|
New data to be presented on Abbott's market-leading XIENCE V(R) stent
|
20 May 2009 |
|
Abbott Reports 16 Percent Earnings Growth in First Quarter
|
17 April 2009 |
|
The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent
|
13 March 2009 |
|
Abbott Successfully Completes Tender Offer for Shares of Advanced Medical Optics
|
25 February 2009 |
|
Abbott Receives European Commission Clearance on Acquisition of Advanced Medical Optics
|
23 February 2009 |
|
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter
|
21 January 2009 |
|
Abbott Introduces RealTime Molecular Assay in Europe for Detection of HPV Infection
|
14 January 2009 |
|
First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management
|
16 December 2008 |
|
Abbott Reports Strong Sales and Earnings Growth in Third Quarter
|
16 October 2008 |
|
Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania
|
30 August 2008 |
|
Abbott Reports Stronger-than-Expected Sales and Earnings Growth in Second Quarter
|
17 July 2008 |
|
Abbott and Partnership for a Drug-Free America Launch 'Not In My House'
|
25 June 2008 |
|
Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR
|
02 June 2008 |
|
Abbott, Takeda Conclude TAP Joint Venture
|
02 May 2008 |
|
Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter
|
17 April 2008 |
|
International Federation of Clinical Chemistry Forms Partnership With the Labs Are Vital(TM)
|
04 April 2008 |
|
First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
|
14 March 2008 |
|
Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin)
|
16 February 2008 |